NEW YORK (Reuters Health) – A single negative whole-leg compression ultrasound (CUS) can effectively rule out deep vein thrombosis (DVT) in many patients, according to a meta-analysis in…
NEW YORK (Reuters Health) – Whether clopidogrel is abruptly stopped or slowly tapered, there is no evidence of a rebound in platelet activity, German researchers report. They point…
NEW YORK (Reuters Health) – Performing coronary artery bypass graft (CABG) surgery in high-risk patients without placing them on cardiopulmonary bypass does not increase their risk of short-term…
NEW YORK (Reuters Health) – For hepatocellular carcinomas (HCC) larger than 2 cm, radiofrequency ablation (RFA) is the best ablative therapy, a meta-analysis shows – but for smaller…
NEW YORK (Reuters Health) – Adding trastuzumab (Herceptin) to standard chemotherapy can significantly improve event-free survival in women with HER2-positive locally advanced or inflammatory breast cancer, according to…
NEW YORK (Reuters Health) – L-carnitine supplements can improve liver function, liver histology and other manifestations of nonalcoholic steatohepatitis (NASH), Italian researchers say. “L-carnitine supplementation induces regression of…
NEW YORK (Reuters Health) – Tight glycemic control may increase the risks of mortality and cardiovascular disease, new research suggests. Moderate control, with glycosylated hemoglobin A1c (HbA1c) levels…
NEW YORK (Reuters Health) – In patients with hypertensive nephropathy and metabolic acidosis, alkali treatment reduces tubulointerstitial injury and slows the decline in glomerular filtration rate (GFR), a…
NEW YORK (Reuters Health) – Starting heparin in the emergency department (ED) rather than after admission may improve the survival of patients with acute pulmonary embolism (PE), according…
NEW YORK (Reuters Health) – Only two visits to the pulmonary function lab — one for pre- and post-bronchodilatory spirometry and one for a methacholine challenge test —…
